June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Cell signaling pathways involved in 8-OH-DPAT dependent neuroprotection
Author Affiliations & Notes
  • Shreya Datta
    Ophthalmology, Casey Eye Institute OHSU, Portland, OR
  • Renee C Ryals
    Ophthalmology, Casey Eye Institute OHSU, Portland, OR
  • Aaron Coyner
    Ophthalmology, Casey Eye Institute OHSU, Portland, OR
  • Mark E Pennesi
    Ophthalmology, Casey Eye Institute OHSU, Portland, OR
  • Footnotes
    Commercial Relationships Shreya Datta, None; Renee Ryals, None; Aaron Coyner, None; Mark Pennesi, Sucampo (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1987. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Shreya Datta, Renee C Ryals, Aaron Coyner, Mark E Pennesi; Cell signaling pathways involved in 8-OH-DPAT dependent neuroprotection. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1987.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Studies have shown that the 5-HT1A receptor agonist (±)-8-Hydroxy-2-dipropylaminotetralin (8-OH-DPAT) can protect the retina from light induced retinopathy. However, the downstream signaling pathways have yet to be elucidated. The purpose of these experiments was to investigate the signaling pathways involved in neuroprotection associated with 5HT1A receptor activation.

Methods: Two-month-old BALB/c mice were injected intraperitoneally (IP) with 8-OH-DPAT (10 mg/kg). Naïve (un-injected) mice and saline injected mice served as controls. At 1h, 6h, 24h and 48h post-injection retinas were harvested and total protein was extracted. SDS-PAGE electrophoresis was performed using 30 µg of total retinal protein from each animal to study the temporal kinetics of signaling pathways. Blots were probed with cell signaling antibodies specific to Erk1/2, phospho-Erk1/2, Akt, phospho-Akt, STAT3 and phospho-STAT3 antibodies.

Results: Western blot analysis showed presence of total Erk1/2, STAT3 and Akt at all time points tested. At 1h, 6h, 24h and 48h post-injection there was no activation of STAT3. At 1h, 6h, 24h and 48h there was activation of both Erk1/2 and Akt. However, activation was the same in control retinas and experimental retinas.

Conclusions: One IP injection of 8-OH-DPAT did not activate STAT3 nor did it alter activation of Erk1/2 or Akt. Future studies will examine these same pathways after multiple IP injections of 8-OH-DPAT consistent with reported administration of this drug in light induced retinopathy models. In addition, alternative signaling pathways will be investigated for their role in 5-HT1A specific neuroprotection.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×